KRT2 (P35908) variants and mutations
KRT2 (also known as P35908) is a human protein-coding gene encoding a keratin, type II cytoskeletal 2 epidermal protein. It reinforces differentiated keratinocytes in the upper epidermis and contributes to barrier integrity. Dominant pathogenic variants cause superficial epidermolytic ichthyosis, typically with blistering or hyperkeratosis that is milder and more superficial than classic epidermolytic ichthyosis. This analysis covers 1,139 KRT2 variants and mutations. Of these, 82% have computational variant effect predictions. Disease context includes superficial epidermolytic ichthyosis, exfoliative ichthyosis, and hereditary disease. Example KRT2 variants include S2T, C3*, and C3G.
Variant analysis overview
- Gene: KRT2
- Protein: P35908
- UniProt accession: P35908
- Organism: Homo sapiens
- Variants analyzed: 1139
- Variant scope: all variants
- Completed: 2026-08-22
Variant and mutation evidence
- Variant composition: 837 unspecified-consequence records; 1 stop retained variant; 2 stop lost; 12 frameshift variants; 120 synonymous variants; 148 missense variants; 13 in-frame deletions; 3 splice-region variants; 1 in-frame insertions; 5 stop-gained variants
- Prediction scores: 932 variants have prediction scores (82% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: superficial epidermolytic ichthyosis, exfoliative ichthyosis, hereditary disease, Vertigo, erythrokeratodermia variabilis, lamellar ichthyosis, Dowling-Degos disease, Localized epidermolysis bullosa simplex, epidermolysis bullosa simplex 2E, with migratory circinate erythema, Epidermolysis bullosa simplex with circinate migratory erythema, disseminated superficial actinic porokeratosis, ichthyosis, annular epidermolytic, 2.
Protein structure and variant hotspots
- Protein features: 1 domains; 5 post-translational modification sites.
- Structural context: 535 variants have structural context.
- PTM context: 7 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable KRT2 variants
Examples include S2T, C3*, C3G, I5N, C7R, R10*, R10Q, R12G. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- S2T (p.Ser2Thr), TOPMed rs1196644892, gnomAD rs1196644892, REVEL 0.50, CADD 22.80
- C3* (p.Cys3Ter), TOPMed rs1941264895
- C3G (p.Cys3Gly), ExAC rs746684651, gnomAD rs746684651, REVEL 0.35, CADD 17.70
- I5N (p.Ile5Asn), Ensembl rs2120957534, REVEL 0.12, CADD 14.50
- C7R (p.Cys7Arg), gnomAD rs1263477050, REVEL 0.26, CADD 17.20
- R10* (p.Arg10Ter), gnomAD rs896757160, CADD 36.00
- R10Q (p.Arg10Gln), ExAC rs778051806, TOPMed rs778051806, gnomAD rs778051806, REVEL 0.23, CADD 15.50
- R12G (p.Arg12Gly), TOPMed rs1287579252, gnomAD rs1287579252, REVEL 0.25, CADD 13.10
- R12T (p.Arg12Thr), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- G13E (p.Gly13Glu), rs1337082248, NCI-TCGA Cosmic COSV5901, TOPMed rs1337082248, gnomAD rs1337082248, REVEL 0.45, CADD 23.30, Variant assessed as somatic; moderate impact.
- G13R (p.Gly13Arg), rs1407901940, NCI-TCGA Cosmic COSV1005, gnomAD rs1407901940, REVEL 0.44, CADD 24.70, Variant assessed as somatic; moderate impact.
- G14E (p.Gly14Glu), gnomAD rs1385900751
- G15S (p.Gly15Ser), TOPMed rs1388086081, gnomAD rs1388086081, REVEL 0.38, CADD 19.60
- G15V (p.Gly15Val), NCI-TCGA TCGA novel, REVEL 0.42, CADD 20.70, Variant assessed as somatic; moderate impact.
- G18E (p.Gly18Glu), ExAC rs755477904, TOPMed rs755477904, gnomAD rs755477904, REVEL 0.40, CADD 14.60
- G18R (p.Gly18Arg), rs779454673, ClinGen CA6585984, ClinVar RCV000405109, ExAC rs779454673, REVEL 0.32, CADD 15.80, Uncertain significance, Ichthyosis bullosa of Siemens
- F19S (p.Phe19Ser), ExAC rs753933142, REVEL 0.27, CADD 12.30
- R20L (p.Arg20Leu), TOPMed rs897318947, gnomAD rs897318947, REVEL 0.24, CADD 16.80, Uncertain significance
- R20Q (p.Arg20Gln), TOPMed rs897318947, gnomAD rs897318947, REVEL 0.12, CADD 16.40, Uncertain significance, Inborn genetic diseases
- R20W (p.Arg20Trp), rs141817495, ClinGen CA6585981, ClinVar RCV000337694, ClinVar RCV000881424, REVEL 0.38, CADD 22.60, Benign, not provided; Ichthyosis bullosa of Siemens
- G21S (p.Gly21Ser), Ensembl rs1941263789, REVEL 0.26, CADD 17.10
- F22L (p.Phe22Leu), rs756350391, ClinGen CA6585980, ClinVar RCV003729801, ExAC rs756350391, REVEL 0.35, CADD 23.50, Uncertain significance, not provided
- S23G (p.Ser23Gly), TOPMed rs1265452262, gnomAD rs1265452262, REVEL 0.38, CADD 23.10
- S24C (p.Ser24Cys), gnomAD rs910875953, REVEL 0.42, CADD 22.00
- S24N (p.Ser24Asn), gnomAD rs1215349793
- S24R (p.Ser24Arg), 1000Genomes rs375338538, ESP rs375338538, ExAC rs375338538, TOPMed rs375338538, REVEL 0.41, CADD 2.05, Likely benign
- G25A (p.Gly25Ala), Ensembl rs2120957302
- G25S (p.Gly25Ser), rs370724968, ClinGen CA6585976, ClinVar RCV002670490, ESP rs370724968, REVEL 0.19, CADD 15.30, Uncertain significance, Inborn genetic diseases
- A27G (p.Ala27Gly), 1000Genomes rs574869727, ExAC rs574869727, gnomAD rs574869727, REVEL 0.41, CADD 26.70
- A27V (p.Ala27Val), 1000Genomes rs574869727, ExAC rs574869727, gnomAD rs574869727, REVEL 0.34, CADD 23.30
- V28A (p.Val28Ala), Ensembl rs1592258074
- V28M (p.Val28Met), gnomAD rs1352721944, REVEL 0.25, CADD 16.70
- V29L (p.Val29Leu), ExAC rs770439539, gnomAD rs770439539, REVEL 0.12, CADD 9.11
- S30T (p.Ser30Thr), TOPMed rs1941263115, REVEL 0.22, CADD 9.97
- G31A (p.Gly31Ala), TOPMed rs1329013108, gnomAD rs1329013108, REVEL 0.25, CADD 18.10
- G31C (p.Gly31Cys), Ensembl rs1941263067
- G31D (p.Gly31Asp), NCI-TCGA Cosmic COSV1005, TOPMed rs1329013108, gnomAD rs1329013108, REVEL 0.21, CADD 22.40, Variant assessed as somatic; moderate impact.
- G32A (p.Gly32Ala), ExAC rs760252823, gnomAD rs760252823, REVEL 0.12, CADD 16.20
- S33I (p.Ser33Ile), ExAC rs772907181, TOPMed rs772907181, gnomAD rs772907181, REVEL 0.45, CADD 23.30
- S33N (p.Ser33Asn), ExAC rs772907181, TOPMed rs772907181, gnomAD rs772907181
- R34G (p.Arg34Gly), 1000Genomes rs35460418, ESP rs35460418, ExAC rs35460418, TOPMed rs35460418, Benign
- R34Q (p.Arg34Gln), 1000Genomes rs375327233, ExAC rs375327233, TOPMed rs375327233, gnomAD rs375327233, REVEL 0.34, CADD 23.50, Uncertain significance, Ichthyosis bullosa of Siemens
- R34W (p.Arg34Trp), rs35460418, ClinGen CA6585969, ClinVar RCV000959926, ClinVar RCV001111993, REVEL 0.41, CADD 22.00, Benign, not provided; Ichthyosis bullosa of Siemens
- R35G (p.Arg35Gly), ExAC rs779176929, TOPMed rs779176929, REVEL 0.20, CADD 12.40
- T37A (p.Thr37Ala), ExAC rs749830972, TOPMed rs749830972, gnomAD rs749830972, REVEL 0.14, CADD 7.71
- T37I (p.Thr37Ile), Ensembl rs1941262424
- T37P (p.Thr37Pro), ExAC rs749830972, TOPMed rs749830972, gnomAD rs749830972, REVEL 0.28, CADD 11.60
- S38P (p.Ser38Pro), Ensembl rs1592258048
- S39N (p.Ser39Asn), ESP rs376095204, TOPMed rs376095204, gnomAD rs376095204, REVEL 0.30, CADD 22.40
- S39T (p.Ser39Thr), ESP rs376095204, TOPMed rs376095204, gnomAD rs376095204, REVEL 0.34, CADD 19.20
- S41F (p.Ser41Phe), TOPMed rs1941262157, gnomAD rs1941262157, REVEL 0.50, CADD 22.90
- S41P (p.Ser41Pro), ESP rs144848746, ExAC rs144848746, gnomAD rs144848746
- C42* (p.Cys42Ter), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- C42F (p.Cys42Phe), NCI-TCGA Cosmic COSV5901, REVEL 0.28, CADD 20.50, Uncertain significance, Inborn genetic diseases
- C42Y (p.Cys42Tyr), NCI-TCGA Cosmic COSV5901, Variant assessed as somatic; moderate impact.
- S44N (p.Ser44Asn), gnomAD rs1469049697
- S44R (p.Ser44Arg), ESP rs372684240, TOPMed rs372684240, gnomAD rs372684240, REVEL 0.23, CADD 19.20
- R45C (p.Arg45Cys), rs202186833, ClinGen CA6585961, ClinVar RCV000280171, ClinVar RCV005090451, REVEL 0.56, CADD 24.50, Benign/Likely benign, not provided; Ichthyosis bullosa of Siemens
- R45G (p.Arg45Gly), ESP rs202186833, ExAC rs202186833, TOPMed rs202186833, gnomAD rs202186833, REVEL 0.22, CADD 19.10, Benign
- R45H (p.Arg45His), rs149447253, ClinGen CA6585960, ClinVar RCV000372292, ClinVar RCV001494821, REVEL 0.29, CADD 22.10, Likely benign, not provided; Ichthyosis bullosa of Siemens
- R45L (p.Arg45Leu), 1000Genomes rs149447253, ESP rs149447253, ExAC rs149447253, TOPMed rs149447253, REVEL 0.41, CADD 21.90, Likely benign
- R45S (p.Arg45Ser), ESP rs202186833, ExAC rs202186833, TOPMed rs202186833, gnomAD rs202186833, REVEL 0.40, CADD 18.40, Benign
- H46R (p.His46Arg), ExAC rs752493825, TOPMed rs752493825, gnomAD rs752493825, REVEL 0.10, CADD 15.00
- H46Y (p.His46Tyr), gnomAD rs1199795984, REVEL 0.22, CADD 13.50
- G47C (p.Gly47Cys), TOPMed rs1304951872, gnomAD rs1304951872, REVEL 0.54, CADD 24.50
- G47D (p.Gly47Asp), ESP rs139461169, ExAC rs139461169, TOPMed rs139461169, gnomAD rs139461169, REVEL 0.42, CADD 21.40, Uncertain significance, Inborn genetic diseases
- G48D (p.Gly48Asp), TOPMed rs1363950058, gnomAD rs1363950058, REVEL 0.45, CADD 18.70, Uncertain significance, Inborn genetic diseases
- G48V (p.Gly48Val), TOPMed rs1363950058, gnomAD rs1363950058
- G49D (p.Gly49Asp), ExAC rs753778046, TOPMed rs753778046, gnomAD rs753778046, REVEL 0.42, CADD 17.20
- G49S (p.Gly49Ser), ExAC rs754850936, gnomAD rs754850936, REVEL 0.32, CADD 15.00
- G50D (p.Gly50Asp), gnomAD rs1319620796, REVEL 0.43, CADD 16.20
- G50S (p.Gly50Ser), ExAC rs766363551, gnomAD rs766363551, REVEL 0.28, CADD 5.77
- G51E (p.Gly51Glu), TOPMed rs1373746740, gnomAD rs1373746740, REVEL 0.43, CADD 23.00
- G51R (p.Gly51Arg), TOPMed rs200226673, gnomAD rs200226673, REVEL 0.51, CADD 9.49
- G52A (p.Gly52Ala), NCI-TCGA TCGA novel, REVEL 0.37, CADD 14.60, Variant assessed as somatic; high impact.
- G52D (p.Gly52Asp), ExAC rs767158226, gnomAD rs767158226, REVEL 0.49, CADD 22.40
- F53L (p.Phe53Leu), 1000Genomes rs142748186, ESP rs142748186, ExAC rs142748186, TOPMed rs142748186, REVEL 0.15, CADD 1.85, Uncertain significance, Inborn genetic diseases
- G54C (p.Gly54Cys), ExAC rs749739311, TOPMed rs749739311, gnomAD rs749739311
- G54R (p.Gly54Arg), ExAC rs749739311, TOPMed rs749739311, gnomAD rs749739311, REVEL 0.52, CADD 16.00
- G54S (p.Gly54Ser), ExAC rs749739311, TOPMed rs749739311, gnomAD rs749739311, REVEL 0.41, CADD 12.80
- G57A (p.Gly57Ala), TOPMed rs1242487698, gnomAD rs1242487698, REVEL 0.36, CADD 17.00
- G57D (p.Gly57Asp), TOPMed rs1242487698, gnomAD rs1242487698, REVEL 0.42, CADD 23.20
- G57S (p.Gly57Ser), TOPMed rs1476306102, gnomAD rs1476306102, REVEL 0.27, CADD 11.20
- G59D (p.Gly59Asp), NCI-TCGA TCGA novel, REVEL 0.47, CADD 19.50, Variant assessed as somatic; moderate impact.
- G59S (p.Gly59Ser), 1000Genomes rs553386913, ExAC rs553386913, TOPMed rs553386913, gnomAD rs553386913, REVEL 0.17, CADD 10.70
- G59V (p.Gly59Val), gnomAD rs1484637446
- S60C (p.Ser60Cys), gnomAD rs1941259989, REVEL 0.54, CADD 23.90
- S60N (p.Ser60Asn), ExAC rs745907775, gnomAD rs745907775, REVEL 0.41, CADD 23.20
- R61Q (p.Arg61Gln), rs757450461, NCI-TCGA Cosmic COSV5901, ExAC rs757450461, REVEL 0.26, CADD 15.50, Variant assessed as somatic; moderate impact.
- R61W (p.Arg61Trp), rs376889647, ClinGen CA6585941, ClinVar RCV002183045, ESP rs376889647, REVEL 0.29, CADD 20.80, Benign, not provided
- S62N (p.Ser62Asn), ESP rs150554132, ExAC rs150554132, TOPMed rs150554132, gnomAD rs150554132, REVEL 0.45, CADD 23.00
- L63I (p.Leu63Ile), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- V64A (p.Val64Ala), gnomAD rs1271102595, REVEL 0.28, CADD 17.90
- L66F (p.Leu66Phe), TOPMed rs1331070675, gnomAD rs1331070675, REVEL 0.36, CADD 24.30
- L66I (p.Leu66Ile), NCI-TCGA Cosmic COSV1005, Variant assessed as somatic; moderate impact.
- L66P (p.Leu66Pro), ExAC rs754762716, TOPMed rs754762716, gnomAD rs754762716, REVEL 0.63, CADD 25.50, Uncertain significance, Inborn genetic diseases
- G67E (p.Gly67Glu), rs1319518447, NCI-TCGA Cosmic COSV5901, TOPMed rs1319518447, gnomAD rs1319518447, REVEL 0.46, CADD 23.90, Variant assessed as somatic; moderate impact.
- G68A (p.Gly68Ala), ExAC rs756077444, TOPMed rs756077444, gnomAD rs756077444, REVEL 0.28, CADD 21.90
- G68R (p.Gly68Arg), ExAC rs766275520, gnomAD rs766275520, REVEL 0.50, CADD 24.00
- T69A (p.Thr69Ala), ESP rs373485048, ExAC rs373485048, TOPMed rs373485048, gnomAD rs373485048, REVEL 0.10, CADD 5.60
- T69P (p.Thr69Pro), ESP rs373485048, ExAC rs373485048, TOPMed rs373485048, gnomAD rs373485048, REVEL 0.18, CADD 12.60
- T69S (p.Thr69Ser), rs2498608251, ClinGen CA384944834, ClinVar RCV003204727, REVEL 0.24, CADD 0.10, Likely benign, Inborn genetic diseases
- K70E (p.Lys70Glu), gnomAD rs1168689867, REVEL 0.36, CADD 22.20
- K70N (p.Lys70Asn), Ensembl rs1941259131
- S71R (p.Ser71Arg), ExAC rs766952518, gnomAD rs766952518, REVEL 0.17, CADD 18.00
- I72N (p.Ile72Asn), ExAC rs761465850, TOPMed rs761465850, gnomAD rs761465850, REVEL 0.36, CADD 22.70
- I72T (p.Ile72Thr), ExAC rs761465850, TOPMed rs761465850, gnomAD rs761465850, REVEL 0.29, CADD 19.00
- I74V (p.Ile74Val), gnomAD rs1941258978, REVEL 0.09, CADD 12.20
- S75N (p.Ser75Asn), TOPMed rs1181021660, gnomAD rs1181021660, REVEL 0.28, CADD 22.80
- V76A (p.Val76Ala), ExAC rs763900507, gnomAD rs763900507, REVEL 0.29, CADD 21.40
- V76L (p.Val76Leu), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- V76M (p.Val76Met), Ensembl rs1941258851, REVEL 0.23, CADD 21.00
- A77V (p.Ala77Val), gnomAD rs1188059408, REVEL 0.45, CADD 19.20
- G78E (p.Gly78Glu), NCI-TCGA Cosmic COSV5901, Ensembl rs1941258636, Variant assessed as somatic; moderate impact.
- G78R (p.Gly78Arg), 1000Genomes rs200608478, ExAC rs200608478, TOPMed rs200608478, gnomAD rs200608478, REVEL 0.27, CADD 21.20
- G79E (p.Gly79Glu), TOPMed rs1941258500, REVEL 0.48, CADD 18.10
- G79R (p.Gly79Arg), 1000Genomes rs201527110, TOPMed rs201527110, gnomAD rs201527110, REVEL 0.25, CADD 15.20, Uncertain significance, Inborn genetic diseases
- G80D (p.Gly80Asp), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- G80V (p.Gly80Val), ESP rs148049179, TOPMed rs148049179, REVEL 0.48, CADD 19.20
- G82D (p.Gly82Asp), gnomAD rs1274172865, REVEL 0.45, CADD 17.00
- G84D (p.Gly84Asp), ExAC rs746380399, gnomAD rs746380399, REVEL 0.41, CADD 20.70
- A85S (p.Ala85Ser), rs747178935, NCI-TCGA Cosmic COSV5901, ExAC rs747178935, TOPMed rs747178935, REVEL 0.16, CADD 0.04, Likely benign, Inborn genetic diseases
- A85T (p.Ala85Thr), rs747178935, ClinGen CA6585922, NCI-TCGA Cosmic COSV5901, ClinVar RCV002920034, REVEL 0.18, CADD 0.31, Uncertain significance, Inborn genetic diseases
- A85V (p.Ala85Val), ExAC rs777951065, TOPMed rs777951065, gnomAD rs777951065, REVEL 0.14, CADD 0.14
- A86S (p.Ala86Ser), ExAC rs779847057, TOPMed rs779847057, gnomAD rs779847057, REVEL 0.20, CADD 0.02
- A86T (p.Ala86Thr), rs779847057, ExAC rs779847057, TOPMed rs779847057, gnomAD rs779847057, REVEL 0.17, CADD 0.10, Variant assessed as somatic; moderate impact.
- G87R (p.Gly87Arg), rs1421767728, ClinGen CA384944397, ClinVar RCV002678426, TOPMed rs1421767728, REVEL 0.53, CADD 16.50, Uncertain significance, Inborn genetic diseases
- G88* (p.Gly88Ter), ExAC rs755992166, TOPMed rs755992166, gnomAD rs755992166, CADD 35.00
- G88R (p.Gly88Arg), ExAC rs755992166, TOPMed rs755992166, gnomAD rs755992166, REVEL 0.52, CADD 15.60
- R92K (p.Arg92Lys), rs1459622656, ClinGen CA384944256, NCI-TCGA Cosmic COSV5901, ClinVar RCV004412227, REVEL 0.32, CADD 17.30, Uncertain significance, Inborn genetic diseases
- R92S (p.Arg92Ser), ExAC rs763806196, gnomAD rs763806196, REVEL 0.18, CADD 17.00
- G94S (p.Gly94Ser), ExAC rs753059160, gnomAD rs753059160, REVEL 0.15, CADD 9.21
- G95A (p.Gly95Ala), TOPMed rs1480771450, gnomAD rs1480771450, REVEL 0.30, CADD 15.60
- G95S (p.Gly95Ser), TOPMed rs908964735, gnomAD rs908964735, REVEL 0.34, CADD 19.30
- G95V (p.Gly95Val), TOPMed rs1480771450, gnomAD rs1480771450, REVEL 0.38, CADD 16.70
- G97E (p.Gly97Glu), rs1941256831, ClinGen CA384943997, ClinVar RCV001111992, Ensembl rs1941256831, REVEL 0.56, CADD 22.90, Uncertain significance, Ichthyosis bullosa of Siemens
- G97R (p.Gly97Arg), ExAC rs776998809, gnomAD rs776998809, REVEL 0.56, CADD 18.80
- G99D (p.Gly99Asp), ExAC rs773313616, gnomAD rs773313616, REVEL 0.34, CADD 22.80
- G99S (p.Gly99Ser), rs760641107, ClinGen CA6585899, ClinVar RCV002892387, ExAC rs760641107, REVEL 0.18, CADD 14.70, Uncertain significance, Inborn genetic diseases
- S101G (p.Ser101Gly), rs2634041, ClinGen CA6585888, ClinVar RCV000320436, ClinVar RCV001636880, REVEL 0.14, CADD 5.41, Benign, not provided; Ichthyosis bullosa of Siemens
- S101N (p.Ser101Asn), TOPMed rs1220238542, gnomAD rs1220238542, REVEL 0.10, CADD 15.80
- F102L (p.Phe102Leu), Ensembl rs1592257800, REVEL 0.10, CADD 11.10
- G103E (p.Gly103Glu), rs779761041, 1000Genomes rs779761041, ExAC rs779761041, gnomAD rs779761041, REVEL 0.44, CADD 22.80, Variant assessed as somatic; moderate impact.
- G104A (p.Gly104Ala), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- G104C (p.Gly104Cys), gnomAD rs1225472851, REVEL 0.29, CADD 22.20
- G104D (p.Gly104Asp), ExAC rs769475292, gnomAD rs769475292, REVEL 0.30, CADD 15.10
- G105S (p.Gly105Ser), ExAC rs780972647, gnomAD rs780972647, REVEL 0.37, CADD 13.90
- G105V (p.Gly105Val), TOPMed rs918786650
- S106N (p.Ser106Asn), rs74660757, ClinGen CA6585869, ClinVar RCV000886633, ClinVar RCV001109693, REVEL 0.20, CADD 2.51, Benign, Ichthyosis bullosa of Siemens; not provided
- S106R (p.Ser106Arg), 1000Genomes rs569110795, ExAC rs569110795, gnomAD rs569110795, REVEL 0.25, CADD 0.27, Uncertain significance, Inborn genetic diseases
- G107C (p.Gly107Cys), 1000Genomes rs552494206, ExAC rs552494206, gnomAD rs552494206, Uncertain significance
- G107S (p.Gly107Ser), 1000Genomes rs552494206, ExAC rs552494206, gnomAD rs552494206, REVEL 0.38, CADD 12.00, Uncertain significance, Inborn genetic diseases
- S109G (p.Ser109Gly), TOPMed rs1397483757, REVEL 0.06, CADD 9.22
- S109I (p.Ser109Ile), Ensembl rs1941254021, REVEL 0.20, CADD 16.10
- S109R (p.Ser109Arg), TOPMed rs1334548837, REVEL 0.18, CADD 9.05
- G110D (p.Gly110Asp), TOPMed rs1339589023, gnomAD rs1339589023, REVEL 0.30, CADD 22.30
- G110S (p.Gly110Ser), gnomAD rs1160658410, REVEL 0.26, CADD 16.60
- G111S (p.Gly111Ser), TOPMed rs1243502300, gnomAD rs1243502300, REVEL 0.37, CADD 13.10
- G112S (p.Gly112Ser), NCI-TCGA Cosmic COSV5901, Variant assessed as somatic; moderate impact.
- G112V (p.Gly112Val), ESP rs376461950, ExAC rs376461950, TOPMed rs376461950, gnomAD rs376461950, REVEL 0.36, CADD 14.60
- G114A (p.Gly114Ala), ExAC rs766757284, TOPMed rs766757284, gnomAD rs766757284, REVEL 0.45, CADD 16.10, Uncertain significance
- G114D (p.Gly114Asp), rs766757284, ClinGen CA6585858, ClinVar RCV003181216, ExAC rs766757284, REVEL 0.55, CADD 21.60, Uncertain significance, Inborn genetic diseases
- G114R (p.Gly114Arg), 1000Genomes rs76412202, ESP rs76412202, ExAC rs76412202, TOPMed rs76412202, REVEL 0.52, CADD 15.80, Benign
- G114S (p.Gly114Ser), rs76412202, ClinGen CA6585859, ClinVar RCV000888153, ClinVar RCV003955942, REVEL 0.39, CADD 15.40, Benign, not provided
- G114V (p.Gly114Val), ExAC rs766757284, TOPMed rs766757284, gnomAD rs766757284, REVEL 0.58, CADD 21.20, Uncertain significance
- G115E (p.Gly115Glu), gnomAD rs1214663922, REVEL 0.36, CADD 21.70
- G115R (p.Gly115Arg), ExAC rs761267359, gnomAD rs761267359, REVEL 0.37, CADD 22.60
- G115V (p.Gly115Val), NCI-TCGA Cosmic COSV1005, NCI-TCGA Cosmic COSV5901, Variant assessed as somatic; moderate impact.
- G116A (p.Gly116Ala), NCI-TCGA Cosmic COSV1005, Variant assessed as somatic; moderate impact.
- G116R (p.Gly116Arg), rs1941253363, ClinGen CA384943291, ClinVar RCV001109692, TOPMed rs1941253363, REVEL 0.55, CADD 14.50, Uncertain significance, Ichthyosis bullosa of Siemens
- G117A (p.Gly117Ala), TOPMed rs1460209702, gnomAD rs1460209702, REVEL 0.22, CADD 13.20
- G117C (p.Gly117Cys), 1000Genomes rs150026966, ESP rs150026966, ExAC rs150026966, TOPMed rs150026966, REVEL 0.49, CADD 6.84, Uncertain significance, Inborn genetic diseases
- G117R (p.Gly117Arg), 1000Genomes rs150026966, ESP rs150026966, ExAC rs150026966, TOPMed rs150026966, REVEL 0.16, CADD 0.81
- G117S (p.Gly117Ser), 1000Genomes rs150026966, ESP rs150026966, ExAC rs150026966, TOPMed rs150026966, REVEL 0.13, CADD 0.62, Benign, not provided
- G117V (p.Gly117Val), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- G119A (p.Gly119Ala), Ensembl rs1592257686, REVEL 0.43, CADD 21.90
- G121D (p.Gly121Asp), Ensembl rs916634169, REVEL 0.40, CADD 15.70
- R122C (p.Arg122Cys), rs530180060, NCI-TCGA Cosmic COSV5900, 1000Genomes rs530180060, TOPMed rs530180060, REVEL 0.36, CADD 15.30, Uncertain significance, not provided
- R122G (p.Arg122Gly), 1000Genomes rs530180060, TOPMed rs530180060, gnomAD rs530180060, REVEL 0.28, CADD 2.90
- R122H (p.Arg122His), rs774545316, NCI-TCGA Cosmic COSV9904, ExAC rs774545316, gnomAD rs774545316, REVEL 0.26, CADD 14.70, Uncertain significance, Inborn genetic diseases
Public KRT2 analysis runs
- KRT2 analysis run — KRT2 (1,139 variants) — completed 2026-08-22